Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Revenue Recognition (Details Textual)

v3.21.1
Note 2 - Revenue Recognition (Details Textual) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2021
Jun. 30, 2020
Proceeds from Laboratory Services Reimbursed by Medicare   $ 0.5  
Contract with Customer, Liability, Total $ 19.7 19.7 $ 14.2
Contract with Customer, Liability, Revenue Recognized $ 1.6 $ 9.7